SUMMARY During a 7.5-year period ending in June 1977, 220 patients underwent combined aortic valve replacement and myocardial revascularization. Early (30-day) mortality was 5.4% (12 patients), and was significantly affected by the development of perioperative myocardial infarction. For 23 patients with electrocardiographic and enzymatic evidence for definite infarction, hospital mortality was 17%; for 66 patients with probable infarction mortality was 5%; and for 116 patients without evidence for infarction mortality was 3%. The difference in mortality between the definite and no infarction groups was significant (p < 0.01). The incidence of perioperative infarction was influenced by the type of myocardial protection employed during the operative procedure. Definite infarction occurred in 24% of 41 patients who had mild (28-32°C), intermittent hypothermic coronary perfusion, in 9% of 142 patients with hypothermic ischemic arrest (myocardial temperature 20 to 27°C) and in none of 22 patients with hypothermic, potassium-induced cardioplegia (myocardial temperature 8-18°C). The difference in the rate of infarction between the coronary perfusion and the two hypothermic ischemic arrest groups was significant (p < 0.01).
WITH THE INCREASED APPLICATION of coronary arteriography for evaluation of patients with aortic valve disease, particularly those with angina pectoris, many patients with coexisting coronary atherosclerosis and aortic valvular disease are being identified. Combined aortic valve replacement and myocardial revascularization procedures have been performed in several centers.`The early and late results have been variable, and operative mortality has ranged from levels similar to that for aortic valve replacement,"' I to as high as 85%. 3 In addition, longterm follow-up has suggested that the survival of patients with the combined lesions having both valve replacement and revascularization is less than that for patients having aortic valve replacement who have normal coronary arteries.' Since the rationale for combining aortic valve replacement and myocardial revascularization is to reduce the early and late effects of the coronary atherosclerosis, beneficial effects of the combined procedure must be demonstrated to justify its continued use.
This report documents our experience with combined aortic valve replacement and myocardial revascularization during a 7.5-year period, focusing on the determinants of operative risk, particularly the influence of various methods of myocardial protection, and on late survival.
Materials and Methods
Two hundred twenty patients had combined aortic valve replacement and coronary artery grafting between May 1970 and June 1977 at the University of Alabama Medical Center in Birmingham. The results with the first 43 patients have been previously reported. 4 Patients who also required mitral valve replacement, ventricular aneurysmectomy, or resection of the ascending aorta were excluded. There were 178 males (81%) and 42 females (19%). The mean age was 59 years (range 31-80 years), and 88% of the patients were older than 50 years ( fig. 1 ).
All patients were classified symptomatically according to the New York Heart Association (NYHA) classification. Angina pectoris was present in 172 patients (78% Reversed segments of saphenous vein were used in all patients. Replacement of the valve and anastomosis of the grafts to the coronary arteries were performed during one or more periods of aortic clamping. The grafts were anastomosed to the aorta before aortic clamping or while the heart was being rewarmed after closure of the aorta. The mean duration of cardiopulmonary bypass was 108 ± 5.7 minutes (range 44-218 min). One hundred patients received one graft, 75 two grafts, 36 three grafts, and nine four grafts. The mean number of grafts per patient was 1.8 ± 0.2. Bjork-Shiley tilting-disc prostheses were used in 162 patients (74%), various models of the Starr-Edwards ball valve prostheses in 25 patients (1 1%), stent-mounted porcine heterografts in 23 patients (10%), and Braunwald-Cutter prostheses in 10 patients (5%).
Myocardial Protection
Three general techniques of myocardial protection were used during the study. In the early years (1970) (1971) (1972) (1973) , intermittent coronary perfusion (28-32°C) via the coronary ostia and occasionally through the vein grafts when the arteries were severely diseased or totally occluded, was used in 45 patients (20%). Coronary perfusion pressures and flows were monitored, and prolonged periods of ventricular fibrillation were avoided. The duration of myocardial ischemia averaged 40 ± 2.8 minutes (range 3-77 min). Hypothermic ischemic arrest was used in 152 patients (69%) beginning in 1973. With this technique, the myocardium was cooled by reducing the temperature of the blood to 12°C for 2-5 minutes before clamping the aorta. In the majority of cases, external cooling by continuous irrigation of the pericardial cavity with Ringer's solution (4°C) during the period of clamping was also used. This technique resulted in septal myocardial temperatures of 20-27°C. In some patients, intermittent anoxic arrest at 28-32°C for 12-15-minute periods was used to perform one or more of the distal coronary anastomoses before one period of profound cooling for replacement of the aortic valve. The total duration of hypothermic ischemic arrest averaged 59 ± 1.3 minutes (range 30-115 min). Since January 1977, hypothermic cardioplegia using a cold (4°C) potassium-containing (30 mEq/l) solution, perfused into the aortic root or through cannulae in the coronary ostia, has been used in 23 patients (11%). The anterior septal temperature was continuously monitored with a thermistor probe and was maintained below 18°C during the period of aortic occlusion by infusing additional solution. The duration of aortic occlusion averaged 66.4 ± 3.3 minutes (range 30-94 min).
Perioperative Myocardial Injury
Electrocardiograms and serum enzymatic determinations (glutamic oxalic transaminase (SGOT), total and fractionated lactic dehydrogenase (LDH), Anticoagulation with warfarin was begun on the second hospital day and continued indefinitely for those patients who received Bjork-Shiley valves and some models of the Starr-Edwards prosthesis. The patients who received Braunwald-Cutter prostheses or porcine heterografts did not routinely receive longterm anticoagulant therapy. The majority did receive warfarin in the hospital as prophylaxis against lower extremity venous thrombosis and pulmonary embolism.
Follow-up information was obtained from hospital and office records, questionnaires to patients and physicians, and telephone conversations, and was available for all 208 patients who survived operation. The date of the last inquiry was July 1977. The mean duration of followup was 22.5 months, and ranged from 1-84 months. Information was obtained regarding the presence of angina, late postoperative myocardial infarction, embolic episodes and prosthetic endocarditis, the patient's own assessment of his degree of disability, and the physicians' estimate of the NYHA functional class at the last followup. For patients who died, autopsy reports and outside hospital records were reviewed to determine the cause of death.
The
30-Day Mortality
The early (30-day) mortality was 5.4% (12 patients). Eleven of the 12 deaths were from cardiac causes (table 1). One patient had an embolic cerebrovascular accident which resulted in fatal mid-brain injury. Early mortality declined annually and was 4% for the 179 patients operated upon after January 1974. The difference in mortality between the early (1970) (1971) (1972) (1973) and later (1974) (1975) (1976) (1977) When the three techniques of myocardial protection were compared, definite perioperative infarction occurred in 24% of patients with coronary perfusion (10 of 41), 9% of patients with hypothermic ischemic arrest (13 of 142), and in none of the 22 patients in whom hypothermic cardioplegia was employed ( fig.  2 ). The difference in the incidence of definite infarction between the coronary perfusion and the two hypothermic ischemic arrest groups was statistically significant (p < 0.01). There was no difference between the hypothermic ischemic arrest and hypothermic cardioplegia groups. The incidence of probable infarction paralleled the incidence of definite infarction for the three groups ( fig. 2) Discussion The 30-day mortality of 5.4% for combined aortic valve replacement and myocardial revascularization is comparable to that reported for isolated aortic valve replacement from our own institution10 and by other groups.11-13 Early mortality was not influenced by the preoperative functional class, type of valvular lesion, extent of coronary atherosclerosis or the number of grafts inserted. It was significantly affected by the occurrence of definite perioperative myocardial infarction. Early mortality was 17% among the patients sustaining a definite infarction, 5% among patients with probable infarction and 3% among patients with no infarction. The difference in mortality between the definite and no or probable infarction groups was significant (p < 0.01).
The incidence of perioperative myocardial infarction was affected by the type of myocardial protection used. Definite perioperative infarction occurred in 24% of patients with coronary perfusion, 9% of patients with hypothermic ischemic arrest and in none of the patients with hypothermic cardioplegia. The difference between the coronary perfusion group and the two hypothermic groups was significant (p < 0.01). Although the criteria used to document definite or probable myocardial necrosis may have underestimated the actual incidence, they were applied to all patients in this study. Thus, comparison of the incidence of perioperative infarction in the three groups appears valid.
A major difference between the three types of myocardial protection used was the resulting myocardial temperature. Despite longer mean periods of myocardial ischemia with hypothermic techniques (59 and 66 min) than with coronary perfusion (40 min), a lower incidence of myocardial injury was observed. This suggests that hypothermia provides more myo- and long-term (2-4-year) survival of patients who had combined aortic valve replacement and myocardial revascularization are similar to those for patients with isolated aortic valve disease undergoing valve replacement. Since our data indicate that bypass grafting will enhance survival in such patients if operative mortality is not excessive, we believe that combined aortic valve replacement and bypass of all severely stenotic major coronary arteries should be performed in all patients in whom these lesions coexist. Hypothermic ischemic arrest, preferably combined with potassiuminduced cardioplegia, provides the greatest myocardial protection at the present time.
Addendum Between July 1977 and March 1978, an additional 36 patients have undergone aortic valve replacement and myocardial revascularization. Hypothermic cardioplegia was used in 32 patients and hypothermic ischemic arrest in four. There was one death (3%). One hundred forty-six patients with hypothermic ischemic arrest and 54 patients with hypothermic cardioplegia had electrocardiographic and enzymatic data available for comparison. Thirteen (9%) definite infarctions occurred in the hypothermic ischemic arrest group and none in the hypothermic cardioplegia group. This difference was statistically significant (p < 0.05). These data strongly suggest that hypothermic cardioplegia is superior to hypothermic ischemic arrest as a method of myocardial protection for these combined procedures.
